510(k) K864442
K864442 is an FDA 510(k) premarket notification submitted by Merck, Sharp & Dohme for the device "NORFLOXACIN SUSCEPTIBILITY POWDER". The FDA issued a decision of Substantially Equivalent on December 11, 1986. The device falls under product code JTT (Susceptibility Test Powders, Antimicrobial), a Class II device regulated under 21 CFR 866.1640. Merck, Sharp & Dohme has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 11, 1986
- Date Received
- November 12, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Susceptibility Test Powders, Antimicrobial
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type